Literature DB >> 21039072

Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection.

J Torres-Macho1, B Jara-Chinarro, B Suárez-Aliaga, S Gámez-Díez, G García-de-Casasola, B de-Cuenca-Morón.   

Abstract

Pegylated interferon and ribavirin is the treatment of choice in patients with chronic hepatitis C infection. The most common side effects of interferon therapy are flu-like symptoms and psychiatric disorders. Pneumonitis is a less frequent complication associated with non-negligible mortality. We herein report a case of interferon associated pneumonitis in a patient with non-severe clinical symptoms and a normal chest radiography. Physicians should be aware of this entity during the differential diagnosis of respiratory symptoms in patients receiving treatment with interferon due to its high morbimortality and good resolution and outcome after drug withdrawal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039072     DOI: 10.4321/s1130-01082010001000009

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  1 in total

1.  VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature.

Authors:  Yu Jun Wong; Si Yuan Chew; John Chen Hsiang; Prem Harichander Thurairajah; Rahul Kumar; Eng Kiong Teo; Roshni Sadashiv Gokhale; Imran Bin Mohamed Noor; Jessica Tan
Journal:  Clin Mol Hepatol       Date:  2018-09-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.